Patient income level and cancer clinical trial participation Journal Article

Local Library Link: Find It @ Loyola

Authors: Unger, J. M.; Hershman, D. L.; Albain, K. S.; Moinpour, C. M.; Petersen, J. A.; Burg, K.; Crowley, J. J.
Article Title: Patient income level and cancer clinical trial participation
Abstract: PURPOSE: Studies have shown an association between socioeconomic status (SES) and quality of oncology care, but less is known about the impact of patient SES on clinical trial participation. PATIENTS AND METHODS: We assessed clinical trial participation patterns according to important SES (income, education) and demographic factors in a large sample of patients surveyed via an Internet-based treatment decision tool. Logistic regression, conditioning on type of cancer, was used. Attitudes toward clinical trials were assessed using prespecified items about treatment, treatment tolerability, convenience, and cost. RESULTS: From 2007 to 2011, 5,499 patients were successfully surveyed. Forty percent discussed clinical trials with their physician, 45% of discussions led to physician offers of clinical trial participation, and 51% of offers led to clinical trial participation. The overall clinical trial participation rate was 9%. In univariate models, older patients (P = .002) and patients with lower income (P = .001) and education (P = .02) were less likely to participate in clinical trials. In a multivariable model, income remained a statistically significant predictor of clinical trial participation (odds ratio, 0.73; 95% CI, 0.57 to 0.94; P = .01). Even in patients age >/= 65 years, who have universal access to Medicare, lower income predicted lower trial participation. Cost concerns were much more evident among lower-income patients (P .001). CONCLUSION: Lower-income patients were less likely to participate in clinical trials, even when considering age group. A better understanding of why income is a barrier may help identify ways to make clinical trials better available to all patients and would increase the generalizability of clinical trial results across all income levels.
Journal Title: Journal of Clinical Oncology
Volume: 31
Issue: 5
ISSN: 0732-183X
Publisher: Unknown  
Journal Place: United States
Date Published: 2013
Start Page: 536
End Page: 542
Language: eng
DOI/URL:

10.1200/JCO.2012.45.4553

10.1200/JCO.2012.45.4553
Notes: LR: 20130730; GR: CA037429/CA/NCI NIH HHS/United States; GR: U10 CA037429/CA/NCI NIH HHS/United States; GR: U10 CA038926/CA/NCI NIH HHS/United States; JID: 8309333; OID: NLM: PMC3565180 [Available on 02/10/14]; PMCR: 2014/02/10 00:00; 2013/01/07 [aheadofprint]; ppublish